Results 251 to 260 of about 50,913 (300)
Some of the next articles are maybe not open access.
Psychopharmacology and pharmacokinetics
2019The overall physiologic changes associated with aging lead to changes in both pharmacokinetic and pharmacodynamic actions of many medications. This, in turn, leads to changes in the impact that a wide variety of medications have on older adults when compared to younger, healthy individuals. These pharmacokinetic and pharmacodynamic variations can cause
Jacob, Tillmann, Ashley, Reich
openaire +2 more sources
Psychopharmacological Interventions
Child and Adolescent Psychiatric Clinics of North America, 2008Currently stimulants and atomoxetine are the most established treatments for attention deficit hyperactivity disorder (ADHD); more than 170 controlled studies with more than 9000 subjects have documented their efficacy in 50% to 70% of subjects. Although the stimulant medications tend to show a dose-related improvement in ADHD symptoms, atomoxetine is ...
Joseph, Biederman, Thomas J, Spencer
openaire +2 more sources
Psychopharmacology for the elderly
Progress in Neuro-Psychopharmacology, 1981Abstract 1. 1. The use of tricyclic antidepressant agents in the elderly is limited by their anticholinergic and cardiovascular action. Newer compounds, such as mianserin, maprotiline and trazadone may provide advantages in this respect. 2. 2.
W M, Petrie, T A, Ban
openaire +2 more sources
NeuroRehabilitation, 1993
This article examines the use of compounds classified as “cognitive activators” to treat cognitive deficits from neurologic disorders, particularly brain injury. The compounds reviewed include catecholamine agonists, cholinergic agonists, nootropics, gangliosides, and thyrotropin releasing hormone (TRH).
A, McLean +3 more
openaire +2 more sources
This article examines the use of compounds classified as “cognitive activators” to treat cognitive deficits from neurologic disorders, particularly brain injury. The compounds reviewed include catecholamine agonists, cholinergic agonists, nootropics, gangliosides, and thyrotropin releasing hormone (TRH).
A, McLean +3 more
openaire +2 more sources
Psychopharmacology in Pregnancy
The Journal of Perinatal & Neonatal Nursing, 2001Clinicians are confronted with challenging situations when working with women who are pregnant and have a co-existing mental illness. A risk benefit assessment is helpful when identifying possible care interventions. Psychopharmaceutical intervention is a consideration when nonpharmacological interventions are ineffective or inappropriate.
openaire +2 more sources
Ethnicity and psychopharmacology
Journal of Psychopharmacology, 2008Ethnicity is reported to be an important, but often ignored factor in psychopharmacology. However, recent advances in molecular biology and the vision of 'personalised medicine' have spurred a debate on the role of ethnicity in this field. This paper reviews literature on the role of race and ethnicity in psychopharmacology.
Ib, Chaudhry +3 more
openaire +2 more sources
CULTURE AND PSYCHOPHARMACOLOGY
Psychiatric Clinics of North America, 2001In this brief review the authors strive to provide a broad overview of various factors that impinge on psychopharmacotherapeutic practices. The literature revealed an impressive progress in research focusing on the delineation of the biologic mechanisms responsible for cross-ethnic variations in psychotropic metabolism and effects.
K M, Lin, M W, Smith, V, Ortiz
openaire +2 more sources
Developments in Psychopharmacology
Psychosomatics, 1966• The chemical revolution in psychiatry, inaugurated by the advent of tranquilizers ten years ago and advanced by the development of the antidepressants, is one of the most exciting chapters in the history of modern medicine. These drugs have made it possible for the first time for all doctors to unite with psychiatrists in the conquest of mental ...
openaire +2 more sources
Veterinary Clinics of North America: Small Animal Practice
The stress response affects the central nervous system and multiple other systems in the body. Chronic mental and behavioral pathologies are associated with inflammation, dysfunctions in the immune response and an increased risk for other chronic inflammatory and metabolic diseases.
Leticia M S, Dantas, Niwako, Ogata
openaire +2 more sources
The stress response affects the central nervous system and multiple other systems in the body. Chronic mental and behavioral pathologies are associated with inflammation, dysfunctions in the immune response and an increased risk for other chronic inflammatory and metabolic diseases.
Leticia M S, Dantas, Niwako, Ogata
openaire +2 more sources